SBI-756

N/A

Report date: 2023/10/11 09:09:51
NME

Base Information

Drug NameSBI-756
Drug Alias NameSBI-756SBI-0640756
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 4 gamma 1 inhibitors
TargetsEukaryotic translation initiation factor 4 gamma 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesSanford Burnham Prebys Medical Discovery Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A